Department

Medicine

Position

Assistant Professor

Articles

• Chest
  Anani, A, Walters, R, Jackson, I, Loranger, A, Alali, Y, Highley, A. COPD and Psychiatric Illness - A STUDY OF EPEDMIOLOGY AND EFFECTS ON MORTALITY - CHEST 2021
  4, p. A1904 2021
• Chest
  Alghoula, F & Gbadamusi, M & Highley, Adam. : Anemia as a prognostic factor in patients with severe sepsis and septic shock, . . . retrospective study using NIS database_ CHEST
  156, p. A1041 2019
• Journal of Thoracic Disease
  Waste not, want not: diagnostic material found in suction syringe aspirate during endobronchial ultrasound guided transbronchial needle aspiration.Jagan N1, Landeen CA1, Moore DR1, Highley AD1, Walters RW2, DePew ZS1.PMID 31559029 
  11;8, p. 3270-3275 2019
• US Pharmacist
  Highley AD, Cookman C, Morrow LE, Malesker MA.  Severe Asthma: An Update for 2019.  U.S. Pharmacist.  2019;44(7):HS2-HS7. 
  2019 44;7, p. HS2-HS7 2019

Presentations

• Asthma Updates, Everything You Need to Know about COPD, Lung Cancer Screening, Controversies of Respiratory Infections, Deep Vein Thrombosis and Pulmonary Embolism, Challenging Pulmonary Cases 2022
• Creighton University Pulmonary Critical Care Annual CME Conference - Updates in Pulmonary Critical Care Literature – 10/2021 2021
• Feedback in 2021 - Creighton University Pulmonary, Critical Care Grand Rounds – 9/2021 2021
• CHI-Fundamentals of Critical Care Support 2021
• CHI-Pulmonary Function Testing for the Primary Care Physician – 3/10/2021 2021
• Imposter Syndrome - Creighton University Pulmonary, Critical Care Grand Rounds – 10/12/2020 2020
• Medical Management of the Patient with COVID-19 - Creighton University COVID-19 Course – 5/2020 2020
• Acute Respiratory Distress Syndrome o MCC Respiratory Therapy Program Lecture – 10/16/2019 2019
• Emotional Intelligence in Medicine o Creighton University Pulmonary, Critical Care Grand Rounds – 9/9/2019 2019
• Randhawa, S., Griffin, E., Dhingra, M., Hiatt, M., Alberts, J., Noble, V., Highley, A. Portopulmonary Hypertension: A Case Report With Management Considerations. American Thoracic Society International Conference, Dallas, TX. 2019
• Extracorporeal Membrane Oxygenation ECMO o NSRC State Conference – 5/2/2019 2019
• Extracorporeal Membrane Oxygenation ECMO o CHI Cardiovascular Conference – 5/2/2019 2019
• In Case You Missed It! – 2018-2019 Updates in Pulmonary and Critical Care Medicine o Creighton University Pulmonary CME Conference – 4/11/2019 2019
• Sleep Apnea Creighton University Family Medicine CME Conference – 4/6/2019 2019
• Spirometry Interpretation- Creighton University Family Medicine CME Conference – 4/6/2019 2019
• Parekh J, Macaraeg J, Klug M, Loranger A, Highley A. A Rare Case of Rhinovirus Associated Acute Respiratory Distress Syndrome in a 51-Year-Old Womano   SCCM Conference – San Diego, CA – February 2019  2019
• The Feedback Model – Applying Effective Feedback in Educationo   Creighton University Pulmonary, Critical Care Grand Rounds – 8/2/2018  2018
• Creighton University Pulmonary Critical Care Annual CME Conference - In Case You Missed It! – 2019-2020 Updates in Pulmonary and Critical Care 0020

Industry/Corporation

• Sub Investigator - GSK COPD CTT116855: A phase III, 52 week, randomized, double-blind, 3-arm parallel group study, comparing the efficacy, safety and tolerability of the fixed dose triple combination FF/UMEC/VI with the fixed dose dual combinations of FF/VI and UMEC/VI, al administered once-daily in the morning via a dry powder inhaler in subjects with chronic obstructive pulmonary disease

• Sub Investigator - Insmed MAC: A Randomized, Open-Label, Multicenter Study of Liposomal Amikacin for Inhalation (LAI) in Adult Patients with Nontuberculous Mycobacterial (NTM) Lung Infections caused by Mycobacterium avium complex (MAC) that are refractory to treatment

• Sub Investigator - Janssen: Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER)

• Sub Investigator: CXA-NP-11-04: A Prospecteive, Randomized, Double Blind, Multicenter, Phase III Study to Assess the Safety and Efficacy of Intravenous Ceftolozane/Tazobactam Compared with Meropenem in Adult Patients with Ventilated Nosocomial Pneumonia.

• Sub Investigator AstraZeneca: Double-Blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinuim Bromide on Long-Term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD (ASCENT COPD)

• Sub Investigator - AstraZeneca: A Randomized, Double-blind, double dummy, chronic dosing (56 week) Placebo-controlled, Parallel Group, Multicentre, Phase III Study to evaluate the efficacy and safety of 3 doses of Benralizumab in patients with moderate to very severe chronic
  obstructive pulmonary disease with a history of COPD exacerbations

Awards

• Internal Medicine Teaching Award
  Internal Medicine Teaching Award (Divisional) - 2020
  Division
• Internal Medicine Teaching Award
  Internal Medicine Teaching Award (Divisional) – 2019
  Division